After analyzing 2,500 angios over 2 years, I'm done. Nights, weekends—all consumed. I'm tired. My rods & cones would like a word: They miss color. I’m trading cath lab grayscale for summer’s full palette. They miss joy. They miss art. I want summer & paint in my eyes—not

Happy Day After Birthday @taylorswift13 ! In awe of your talent, your honesty, and your business acumen!

Congrats @md_pollack! The creator of @cardiomet_ce & @ckd_ce & @onc_ce has launched two new channels: @rheum_ce and @ibd_ce Not your area of focus??  I know, but we all DO share an understanding of the power, reach& versatility of the tweetorial format so well worth a follow!

Need even MORE 🆓CE/#CME from expert authors right here in Twitter? From the editors of @cardiomet_ce, @ckd_ce, @onc_ce, and @pulmmed_ce, 🆕please check out (and FOLLOW!) @ibd_ce and @rheum_ce and expand your horizons! #FOAMed #MedEd @academiccme @MedTweetorials

Who is your Twitter twin? 👯 @md_pollack = @JJheart_doc md_pollack and JJheart_doc are Twitter twins! #twitterTwin #toasteed https://t.co/K3OkzV7o6O

🆕🆓 #CME from @academiccme: Update on Best Practices for the Prompt and Personalized Management of Patients with #COPD Exacerbations, by William Corrao @BrighamWomens! Click on https://t.co/GUMuTZLLzP. Salute to @GOLD_COPD! Originally presented at @EPulmonaryConf 2022.

FIRST SESSION TONIGHT!! All about #hyperkalemia from the experts, chaired by @BakrisGeorge! Don't miss it! https://t.co/9UMjPxaDyK. 🆓CE/#CME!

Attending #ACEP22? Visit the @academiccme booth today, #1539, to learn about our latest offering, an innovative ECG interpretation and acute cardiac care course originally developed in the Quebec & Montreal 🫀 Institutes! Or go to https://t.co/89yxZ8XwnD for info and to register!

Great to be involved in #CardioSteps with my friend @amrelhadidyy - unfortunately this year for me will be virtual. @Hragy @aymanka @MohanedEgred @Sarah_Moharem @BassemZarif @DrAmirKaki

Read the 12 key points to remember about this scientific statement from the AHA for the management of patients at risk for and with left ventricular thrombus: https://t.co/CxoGBhuYNU #cvACS

Excited to be attending the 2022 Vulnerable Plaque, Vulnerable Patient Meeting, joining a terrific group of faculty to speak on advanced #plaque analysis using #yesCCT. Virtual attendance is an option 👉 https://t.co/VnSjlseynR

righteous

I am a steering committee member of SOS-AMI, a phase 3 study that has the potential to change the paradigm of AMI treatment. Talk to me at #esccongress in Barcelona if you run into me! #iampartofsosami

20) Mark your best response and RETURN TOMORROW for the correct answer and more #ERA22 data on #SGLT2i and #DKD, along with a link to your 🆓CE/#CME. 👏@ClaraGCarro @PepaSolerR @SENefrologia @JonathanNefro @nefrocat @jlgorriz @EdoardoMelilli @SVNefro @CKJsocial @torra_roser

vote!

16) In addition, in the new revision of guidelines, level of #GFR has been lowered to 20 ml/min according to #EMPEROR, #DAPA_CKD, & #CREDENCE trials for the use of #SGLT2i.

15) In European guidelines @goKDIGO, the use of SGLT2i is already first-line drug therapy in #T2D.

14) Taking all of this together, the renal benefits to patients with #T2D of the use of SGLT2i are obvious. Thus, @goKDIGO, @AmDiabetesAssn and @escardio @escardionews guidelines recommend its use as follows, as per a talk at #ERA22 conducted by Dr. Paola Fioretto.

FLOZINATE

4) So let's start with a quick knowledge ✔️. What is the recommended first line drug therapy for #diabetes_mellitus and chronic kidney disease (#CKD)? a. #Metformin b. Metformin + #RAASB c. Metformin + #SGLT2i d. Metformin + SGLT2i + RAASB